Mark Cuban doesn’t talk like a man easing into a comfortable billionaire retirement. He is irritated by inefficiency, allergic to excuses, and convinced that the biggest systems in America can be improved if you stop admiring them and start challenging them.
He seamlessly moves across domains that rarely sit in the same conversation: professional sports, the American healthcare system, and artificial intelligence. On the surface, they appear unrelated, but in Cuban’s telling, they share a common architecture of leverage, incentives, and information asymmetry.
In sports, he learned that the asset isn’t the team, it’s the relationship with the fans. In healthcare, he believes the system is structured to exploit complexity and misaligned incentives. In AI, he sees the most powerful equalizing tool of his lifetime and a looming arms race for anyone slow to adopt it.
As the owner of the Dallas Mavericks, where to many Cuban first became a household name, the caricature is familiar. The animated owner courtside, living and dying with every possession. But his description of ownership is less about control than stewardship.
“People have such passion about their sports teams. I didn’t really own it, I just ran it,” he said. “I’m the curator or the superintendent, but it’s the fans that really own it.”
That idea helps to reframe the business model. The Mavericks or any franchise may have a cap table and a valuation, but in the emotional ledger of a city, it belongs to the people who invest their identity in it. Cuban described the moment at the end of a close game when a shot is in the air “If it goes in, strangers hug and high-five; if it misses, strangers commiserate. It’s just unique,” he said. “No one throws a parade when Google has a good quarter.”
Sports, he argues, is the only business where the emotional return often eclipses the financial one. That doesn’t make it less commercial, it makes it more potent. The emotional bond is precisely why sports has always spawned new business models. Regional sports networks charged premiums because fans demanded access. Merchandise, concerts, and special events followed. Today, arenas anchor entire mixed-use districts where retail, hospitality, gaming converge because predictable traffic and passion create economic gravity.
As the Mavericks evaluate future arena options, Cuban acknowledged what urban planners already know that where you build matters. A sports franchise can catalyze revitalization or miss the opportunity entirely. The arena is not just a building, it’s an economic lever.
The athlete side of the equation has also changed dramatically. Cuban noted that today’s younger players often enter professional leagues with social media followings, brand deals, and even NIL income from college. “Cooper Flagg is already a brand,” he said, referring to the Duke standout who has secured major endorsement deals while still in school. The infrastructure around elite athletes now begins earlier and runs deeper.
But Cuban’s sharper concern is for the vast majority who are not superstars. A minimum contract sounds like generational wealth until taxes, agent fees, and lifestyle costs cut it in half. The psychological tension is real and players must believe they will last 20 years, even if the average career is far shorter. Advisers’ incentives are not always aligned with sober planning. “You don’t want an agent telling you that you suck,” he said bluntly. Yet financial reality demands delayed gratification which is an unappealing message for a 20-year-old who has been the best player on every team he has ever joined.
Sports, in Cuban’s framing, is both opportunity and illusion. The emotional upside is unmatched. The economic downside, for most, is misunderstood.
If sports is powered by passion, healthcare is powered by confusion. Cuban’s critique of the U.S. healthcare system is not abstract; it is mechanical. He has studied the incentives, and he believes the incentives are broken.
His interest deepened during the political debates around repealing and replacing the Affordable Care Act. Then came a cold email from Dr. Alex Oshmyansky about building a compounding pharmacy focused on drugs that can go into shortage, including pediatric cancer medications. The idea that manufacturers could withhold inventory to push prices up struck Cuban as unconscionable. The Martin Shkreli scandal had already highlighted how pricing power could be abused.
At the core of his frustration was a simpler question: how does a patient know what a medication will cost before they buy it? “And the answer was, you don’t,” he said. When a doctor writes a prescription, they ask which pharmacy to send it to, not what the deductible is, what the co-pay will be, or whether a cheaper alternative exists. Price discovery, the most basic feature of functioning markets, is largely absent.
So Cuban and Oshmyansky launched the Mark Cuban Cost Plus Drug Company with a radical premise, price transparency. The company publishes its cost, applies a set markup, and charges a straightforward fee.
“We don’t just sell medications, we sell trust,” Cuban said. He cited a formula he once heard “Trust equals transparency divided by self-interest.” In an industry where consumers expect to be overcharged, transparency becomes a differentiator.
But drug pricing was only the first layer. Cuban described a cascading chain of incentives that distort the broader healthcare market. High deductibles turn insured patients into de facto self-payers. Hospitals extend financing to cover deductibles, effectively becoming subprime lenders just to access insurer reimbursement. Insurers underpay or delay payments, conduct audits, and claw back funds. Providers respond by raising list prices and adding fees. Independent pharmacies and physicians get squeezed hardest.
Both sides, Cuban argued, “look to see the weakest party in the whole chain” and extract value where leverage is minimal. Pharmacy benefit managers, rebates tied to retail list prices, and fee structures layered onto already inflated benchmarks further complicate the system.
His proposed solution is not ideological, it is financial. For companies “After payroll, it’s probably your largest variable expense,” he said. And it is rising faster than revenue for many companies. Every dollar saved on healthcare benefits flows directly to the bottom line.
That logic underpins Cost Plus Wellness, an initiative designed to help self-funded employers contract directly with providers using transparent, upfront pricing. The platform describes itself as an open-source project, publishing contract templates that employers can use to negotiate better terms.
Cuban’s approach is straightforward. If you pay providers upfront, eliminate deductibles and pre-authorizations, and secure lower prices in exchange for certainty and speed. By publishing contracts, he aims to reduce information asymmetry. He has said that Cost Plus Wellness currently operates as an open-source initiative, not a profit center.
He calls this “compassionate capitalism,” a structure in which you can make money while serving customers transparently. Notably, he declined outside investment for Cost Plus Drugs, arguing that external shareholders would introduce competing incentives. In his view, some problems cannot be solved if you are obligated to maximize short-term returns.
If healthcare is about fixing broken incentives, AI is about amplifying capability. Cuban is unequivocal about its magnitude. “Is it the most impactful technology I’ve ever seen. Nothing comes even close,” he said.
But he rejects simplistic narratives. Will AI democratize opportunity or widen inequality? “Yes,” he replied. Both outcomes are possible and likely.
Cuban’s reference point is the PC revolution. He remembers selling Lotus 1-2-3 in the 1980s, when spreadsheet “what-if” modeling was transformative. He also remembers the jobs displaced by digital tools. AI, he believes, will accelerate that pattern.
What makes this wave different is access. With free or low-cost AI tools available, and widespread access to smartphones and laptops, he sees AI as a universal tutor, “every professor and every consultant” available on demand. Personalization, he argues, is the breakthrough. AI can adapt to individual learning styles and pace in ways traditional classrooms cannot.
Through the Mark Cuban Foundation, he launched free AI Bootcamps for high school students, introducing them to AI concepts, ethics, and applications. The program, founded in 2019, aims to increase AI literacy and access, particularly in underserved communities.
In business, his excitement centers on agentic AI with tools that automate tedious tasks. He described one portfolio company using AI to audit shipping invoices, comparing billed charges against actual data and automatically generating credits. The recovered revenue, he said, can amount to thousands of dollars per week.
The point is not novelty, it is margin. Small businesses know exactly which repetitive tasks drain time and money. AI can eliminate those bottlenecks. “It’s dealing with the tedium,” he said, the work that founders know they should address but rarely have time to tackle.
He cautions against anthropomorphizing AI systems. Large language models are “probability machines,” not thinkers. They can hallucinate. But so can humans. Cuban cross-checks outputs across multiple models to reduce error, treating AI like a capable but imperfect analyst.
His most pointed warning concerns intellectual property. In an AI world, publicly available content becomes training data. Cuban has advised CEOs and creators to protect their IP carefully and think strategically about what they disclose. The calculus of patents, publication, and open access is shifting rapidly.
Across sports, healthcare, and AI, Cuban returns to the same core thesis that incentives shape behavior. When incentives reward opacity, complexity flourishes. When incentives reward transparency, trust can scale. When tools compress time and cost, leverage shifts.
With everything he’s accomplished, how does he ultimately want to be remembered?
“Good dad. Great guy, who partied like a rock star and fucked up healthcare.”
